Keywords: glucagon-like peptide-1 receptor agonists, neuroprotection, axonal injury, diabetic neuropathy (DN), multiple sclerosis (MS), Schwann cells, olfactory ensheathing cells, oligodendrocytes 1 Introduction Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from gut enteroendocrine cells in response to food intake, and display insulinotropic actions by stimulating specific G-protein linked GLP-1 receptor (GLP-1R) on the pancreatic cells
Sleep disorders are common and persistent in children with ADHD, and diet also impacts symptomatology
Other GLP-1 alternatives In addition to tirzepatide, liraglutide (Saxenda) is another GLP-1 receptor agonist approved for weight loss
Glutathione can be synthesized from NAC and also requires selenium, which is why youll find 200 mcg of selenium in my Prenatal Plus
But It Is Fighting Back
GLP-1 treatment should be stopped if insufficient weight loss is achieved (typically defined as less than 5% weight loss after 12 weeks at maintenance dose for liraglutide, or as per semaglutide SmPC guidance) or if side effects are intolerable